Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Mathews

Showing results (171-180 of 216) with videos related to

Pageof 22
Sort By:
Blood|March 1, 2012
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapyEzhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, et al.
Transplantation and Cellular Therapy|October 4, 2021
Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications-A single center experience from IndiaBiju George, Uday Kulkarni, Sharon Lionel, et al.
Annals of Clinical Microbiology and Antimicrobials|February 16, 2023
Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapyAbi Manesh Sathya Kumar, Mithun Mohan George, Kundakarla Bhanuprasad, et al.
Frontiers in Pharmacology|June 16, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib <i>in vitro</i> and reduces disease burden <i>in vivo</i>Bharathi M Rajamani, Raveen Stephen Stallon Illangeswaran, Esther Sathya Bama Benjamin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 4, 2019
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantationAswin Anand Pai, Anup J Devasia, John Carl Panetta, et al.
Pharmacogenomics|June 18, 2015
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemiaAjay Abraham, Savitha Varatharajan, Sreeja Karathedath, et al.
British Journal of Haematology|November 20, 2020
Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimensN A Fouzia, Vibhor Sharma, Saravanan Ganesan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian populationSachin David, Sukesh C Nair, G Surender Singh, et al.
Journal of Translational Medicine|January 13, 2026
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemiaDeepshikha Dutta, Akash Maity, Saurabh Kumar Gupta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 8, 2019
Summary of the Highlights of 2019 ASTCT Meeting by iNDUS BMT Group at Chennai, IndiaAjay Sharma, Biju George, Chezian Subhash, et al.
Pageof 22

Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
Blood|March 1, 2012
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapyEzhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, et al.
Transplantation and Cellular Therapy|October 4, 2021
Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications-A single center experience from IndiaBiju George, Uday Kulkarni, Sharon Lionel, et al.
Annals of Clinical Microbiology and Antimicrobials|February 16, 2023
Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapyAbi Manesh Sathya Kumar, Mithun Mohan George, Kundakarla Bhanuprasad, et al.
Frontiers in Pharmacology|June 16, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib <i>in vitro</i> and reduces disease burden <i>in vivo</i>Bharathi M Rajamani, Raveen Stephen Stallon Illangeswaran, Esther Sathya Bama Benjamin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 4, 2019
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantationAswin Anand Pai, Anup J Devasia, John Carl Panetta, et al.
Pharmacogenomics|June 18, 2015
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemiaAjay Abraham, Savitha Varatharajan, Sreeja Karathedath, et al.
British Journal of Haematology|November 20, 2020
Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimensN A Fouzia, Vibhor Sharma, Saravanan Ganesan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
Prevalence of FVIII inhibitors in severe haemophilia A patients: Effect of treatment and genetic factors in an Indian populationSachin David, Sukesh C Nair, G Surender Singh, et al.
Journal of Translational Medicine|January 13, 2026
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemiaDeepshikha Dutta, Akash Maity, Saurabh Kumar Gupta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 8, 2019
Summary of the Highlights of 2019 ASTCT Meeting by iNDUS BMT Group at Chennai, IndiaAjay Sharma, Biju George, Chezian Subhash, et al.
Pageof 22